(2E)-((4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene)(1H-imidazol-1-yl)acetonitrile,
4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene-1-imidazolylacetonitrile,
Lulicon,
luliconazole,
NND 502,
NND-502,
NND502,
Luliconazole,
187164-19-8,
Lulicon,
NND-502,
Luzu,
PR-2699,
NND 502,
UNII-RE91AN4S8G,
RE91AN4S8G,
NCGC00182704-01,
NCGC00182704-02,
CHEBI:34825,
4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene-1-imidazolylacetonitrile,
(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-yl-acetonitrile,
(2E)-2-[(4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-imidazol-1-ylacetonitrile,
NCGC00182704-03,
(R,E)-2-(4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene)-2-(1H-imidazol-1-yl)acetonitrile,
DSSTox_CID_28533,
DSSTox_RID_82805,
DSSTox_GSID_48607,
NND502,
CAS-187164-19-8,
Luliconazole [USAN:INN],
Lulicon (TN),
Imidazole antimycotic,
Luzu (TN),
AC1MHEOF,
Lulicon|||NND 502,
SCHEMBL342362,
GTPL7366,
Luliconazole (JAN/USAN/INN),
CHEMBL2105689,
DTXSID3048607,
Luliconazole, >=98% (HPLC),
ZINC3929486,
Tox21_112942,
Tox21_112974,
MFCD00953915,
s4258,
AKOS015897320,
Tox21_112974_1,
AM84645,
BCP9000863,
CS-0587,
DB08933,
DS-3278,
SB18987,
AN-15036,
HY-14283,
SW219226-1,
A11481,
C13478,
D01980,
W-5249,
164L198,
SR-01000945039,
SR-01000945039-1,
UNII-5JA16R08FJ component YTAOBBFIOAEMLL-REQDGWNSSA-N,
(-)-(E)-((4R)-4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene)(1H-imidazol-1-yl)acetonitrile,
1H-Imidazole-1-acetonitrile, alpha-((4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene)-, (alphaE)-,
2-[(2E,4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene]-2-(1H-imidazol-1-yl)acetonitrile,
Lulifin,
Luliconazole [INN],
D0U4XJ,
Carboxymethylcellulose sodium,
C14H9Cl2N3S2,
C14-H9-Cl2-N3-S2,
JA-004,
JA-005,
ACN-036087,
CID3003141,
CS-O-30625,
C112528,
(2E)-((4R)-4-(2,4-dichlorophenyl)-1,3-dithiolan-2-ylidene)(1H-imidazol-1-yl)acetonitrile,